Innovative Partnership between PharosAI and 10x Genomics Aims to Revolutionize Cancer Research with AI Technology#United_Kingdom#Cancer_Research#Pleasanton,_California #10x_Genomics#PharosAI
Innovative Partnership between PharosAI and 10x Genomics Aims to Revolutionize Cancer Research with AI Technology
PharosAI collaborates with 10x Genomics to leverage AI and spatial biology in creating a vast multimodal cancer dataset, enhancing diagnostic capabilities and treatment options.
third-news.com
February 4, 2026 at 2:43 PM
Innovative Partnership between PharosAI and 10x Genomics Aims to Revolutionize Cancer Research with AI Technology#United_Kingdom#Cancer_Research#Pleasanton,_California #10x_Genomics#PharosAI
Tomonori Tomura's Contribution on World Cancer Day 2026#Japan#Cancer_Research#Tokyo#World_Cancer_Day#Tomonori_Tomura
Tomonori Tomura's Contribution on World Cancer Day 2026
February 4th marks World Cancer Day. Tomonori Tomura from Japan Management Institute LLC expresses gratitude through a donation supporting cancer research.
third-news.com
February 4, 2026 at 1:33 AM
Tomonori Tomura's Contribution on World Cancer Day 2026#Japan#Cancer_Research#Tokyo#World_Cancer_Day#Tomonori_Tomura
LifeCanvas Takes a Revolutionary Step in Cancer Research with New Collaboration#USA#Cambridge#Cancer_Research#LifeCanvas#Harvard_Medical
LifeCanvas Takes a Revolutionary Step in Cancer Research with New Collaboration
LifeCanvas Technologies is partnering with Harvard Medical School's LSP to enhance cancer research through innovative spatial profiling techniques, enabling better treatment options.
third-news.com
February 3, 2026 at 1:14 PM
LifeCanvas Takes a Revolutionary Step in Cancer Research with New Collaboration#USA#Cambridge#Cancer_Research#LifeCanvas#Harvard_Medical
Highlights from Recent Press Releases: Key Industry Updates you Shouldn't Miss#USA#New_York#Cancer_Research#Consumer_Confidence#Wildfire_Prevention
Highlights from Recent Press Releases: Key Industry Updates you Shouldn't Miss
Stay informed with the latest developments from industries via key press releases covering consumer confidence drops to innovative partnerships.
third-news.com
January 30, 2026 at 11:10 AM
Highlights from Recent Press Releases: Key Industry Updates you Shouldn't Miss#USA#New_York#Cancer_Research#Consumer_Confidence#Wildfire_Prevention
Leveraged Finance Community Unites to Raise £1.6 Million for Melanoma Research#London#United_Kingdom#Cancer_Research#Leveraged_Finance#Melanoma_Research_Alliance
Leveraged Finance Community Unites to Raise £1.6 Million for Melanoma Research
The Leveraged Finance Fights Melanoma event held in London raised £1.6 million for melanoma research, showcasing commitment from the finance community.
third-news.com
January 29, 2026 at 4:35 PM
Leveraged Finance Community Unites to Raise £1.6 Million for Melanoma Research#London#United_Kingdom#Cancer_Research#Leveraged_Finance#Melanoma_Research_Alliance
GiveByCruising and Blood Cancer United Join Forces to Enhance Blood Cancer Research#United_States#Cancer_Research#Greenville#Blood_Cancer_United#GiveByCruising
GiveByCruising and Blood Cancer United Join Forces to Enhance Blood Cancer Research
GiveByCruising has teamed up with Blood Cancer United to support vital research into blood cancers. Their goal is to extend the lives of patients significantly.
third-news.com
January 29, 2026 at 2:53 PM
GiveByCruising and Blood Cancer United Join Forces to Enhance Blood Cancer Research#United_States#Cancer_Research#Greenville#Blood_Cancer_United#GiveByCruising
Tampa General Hospital Set to Host Groundbreaking Cancer Research Symposium in 2026#USA#Cancer_Research#Tampa#Tampa_General_Hospital#USF_Health
Tampa General Hospital Set to Host Groundbreaking Cancer Research Symposium in 2026
In March 2026, Tampa General Hospital and the USF Health Morsani College of Medicine will host the 'Microbes, Genes & Cancer' Symposium, featuring top researchers.
third-news.com
January 27, 2026 at 10:11 PM
Tampa General Hospital Set to Host Groundbreaking Cancer Research Symposium in 2026#USA#Cancer_Research#Tampa#Tampa_General_Hospital#USF_Health
Top Cancer Researchers Collaborate to Enhance Therapeutic Vaccine Advancements#United_States#New_York#Cancer_Research#Cancer_Vaccine_Coalition#Therapeutic_Vaccines
Top Cancer Researchers Collaborate to Enhance Therapeutic Vaccine Advancements
A groundbreaking think tank unites leading scientists to enhance the development of cancer vaccines, which hold the key to effective immunotherapies against cancer.
third-news.com
January 27, 2026 at 4:19 PM
Top Cancer Researchers Collaborate to Enhance Therapeutic Vaccine Advancements#United_States#New_York#Cancer_Research#Cancer_Vaccine_Coalition#Therapeutic_Vaccines
Brandi Williams Broome Appointed New CEO of V Foundation for Cancer Research#USA#Cancer_Research#Cary,_North_Carolina#V_Foundation#Brandi_Williams
Brandi Williams Broome Appointed New CEO of V Foundation for Cancer Research
The V Foundation has appointed Brandi Williams Broome as its new CEO, effective March 16. Broome's extensive experience in nonprofit leadership is set to drive the foundation's mission forward.
third-news.com
January 27, 2026 at 1:41 PM
Brandi Williams Broome Appointed New CEO of V Foundation for Cancer Research#USA#Cancer_Research#Cary,_North_Carolina#V_Foundation#Brandi_Williams
Okayama University's Professor Yoshisuke Togashi Receives Prestigious Award for Cancer Research in 2027#Japan#Cancer_Research#Okayama#Okayama_University#Yoshisuke_Togashi
Okayama University's Professor Yoshisuke Togashi Receives Prestigious Award for Cancer Research in 2027
Professor Yoshisuke Togashi from Okayama University has been honored with the 22nd Japan Academy Award for his groundbreaking research on cancer immune evasion.
third-news.com
January 18, 2026 at 8:47 AM
Okayama University's Professor Yoshisuke Togashi Receives Prestigious Award for Cancer Research in 2027#Japan#Cancer_Research#Okayama#Okayama_University#Yoshisuke_Togashi
Discovery of CTDNEP1 Gene Offers Hope in Slowing Pancreatic Cancer Progression#Japan#Cancer_Research#Tokyo#pancreatic_cancer#CTDNEP1
Discovery of CTDNEP1 Gene Offers Hope in Slowing Pancreatic Cancer Progression
A groundbreaking discovery has identified the CTDNEP1 gene as a potential suppressor of pancreatic cancer progression, paving the way for early diagnosis and treatment strategies.
third-news.com
January 15, 2026 at 2:09 AM
Discovery of CTDNEP1 Gene Offers Hope in Slowing Pancreatic Cancer Progression#Japan#Cancer_Research#Tokyo#pancreatic_cancer#CTDNEP1
Mark Foundation for Cancer Research Recognizes Emerging Leaders with $3.75 Million for Oncology Innovations#United_States#New_York#Cancer_Research#Mark_Foundation#Emerging_Leader
Mark Foundation for Cancer Research Recognizes Emerging Leaders with $3.75 Million for Oncology Innovations
The Mark Foundation awards five early-career scientists $3.75 million in total to support groundbreaking cancer research, advancing oncology treatment.
third-news.com
January 13, 2026 at 3:55 PM
Mark Foundation for Cancer Research Recognizes Emerging Leaders with $3.75 Million for Oncology Innovations#United_States#New_York#Cancer_Research#Mark_Foundation#Emerging_Leader
NYU Langone Health's New Cancer Treatment Protocols Set to Advance Patient Care#United_States#New_York#Cancer_Research#NYU_Langone#Precision_Oncology
NYU Langone Health's New Cancer Treatment Protocols Set to Advance Patient Care
The Perlmutter Cancer Center announces upcoming molecular profiling protocols to enhance cancer treatment monitoring for patients.
third-news.com
January 12, 2026 at 1:45 PM
NYU Langone Health's New Cancer Treatment Protocols Set to Advance Patient Care#United_States#New_York#Cancer_Research#NYU_Langone#Precision_Oncology
Johnson & Johnson Honors Dr. Tony Hunter with 2025 Dr. Paul Janssen Award for Cancer Research#USA#Cancer_Research#New_Brunswick#J&J#Tony_Hunter
Johnson & Johnson Honors Dr. Tony Hunter with 2025 Dr. Paul Janssen Award for Cancer Research
Johnson & Johnson proudly announces Dr. Tony Hunter as the recipient of the 2025 Dr. Paul Janssen Award, acknowledging his pioneering contributions to cancer research.
third-news.com
January 8, 2026 at 1:29 PM
Johnson & Johnson Honors Dr. Tony Hunter with 2025 Dr. Paul Janssen Award for Cancer Research#USA#Cancer_Research#New_Brunswick#J&J#Tony_Hunter
Caris Life Sciences Teams Up with Genentech for Cancer Research Breakthroughs#United_States#Cancer_Research#Caris_Life_Sciences#Irving#Genentech
Caris Life Sciences Teams Up with Genentech for Cancer Research Breakthroughs
Caris Life Sciences has partnered with Genentech to explore new cancer treatment targets, aiming to enhance precision medicine and address unmet clinical needs.
third-news.com
December 16, 2025 at 2:03 PM
Caris Life Sciences Teams Up with Genentech for Cancer Research Breakthroughs#United_States#Cancer_Research#Caris_Life_Sciences#Irving#Genentech
Breakthrough Proton Therapy Study Reveals Enhanced Survival Rates for Head and Neck Cancer Patients#United_States#Jacksonville#Cancer_Research#Proton_Therapy#Medical_Breakthroughs
Breakthrough Proton Therapy Study Reveals Enhanced Survival Rates for Head and Neck Cancer Patients
A recent study reveals that proton therapy significantly increases survival rates and reduces side effects for head and neck cancer patients, marking a major step forward in cancer treatment.
third-news.com
December 11, 2025 at 11:35 PM
Breakthrough Proton Therapy Study Reveals Enhanced Survival Rates for Head and Neck Cancer Patients#United_States#Jacksonville#Cancer_Research#Proton_Therapy#Medical_Breakthroughs
Indivumed Deepens Collaboration with University of Rochester for Innovative Cancer Therapies#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed Deepens Collaboration with University of Rochester for Innovative Cancer Therapies
Indivumed and the University of Rochester Medical Center are advancing their collaboration for innovative, patient-centered cancer therapies through enhanced data methodologies.
third-news.com
December 11, 2025 at 1:46 PM
Indivumed Deepens Collaboration with University of Rochester for Innovative Cancer Therapies#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed and University of Rochester's Expanded Collaborative Efforts in Cancer Therapy Discoveries#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed and University of Rochester's Expanded Collaborative Efforts in Cancer Therapy Discoveries
Indivumed and the University of Rochester Medical Center deepen their collaboration to advance patient-centric cancer therapies, aiming to accelerate the discovery of innovative treatments.
third-news.com
December 10, 2025 at 3:14 PM
Indivumed and University of Rochester's Expanded Collaborative Efforts in Cancer Therapy Discoveries#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed Partners with URMC: Pioneering Patient-Centric Cancer Research#Cancer_Research#URMC#Indivumed
Indivumed Partners with URMC: Pioneering Patient-Centric Cancer Research
Indivumed is joining forces with the University of Rochester Medical Center, aiming to enhance cancer therapy discovery through patient-centric methodologies and cutting-edge research.
third-news.com
December 10, 2025 at 1:42 PM
Indivumed Partners with URMC: Pioneering Patient-Centric Cancer Research#Cancer_Research#URMC#Indivumed
Menarini and Stemline Reveal Phase 2 Data for Elacestrant in Metastatic Breast Cancer#USA#New_York#Cancer_Research#Menarini#Elacestrant
Menarini and Stemline Reveal Phase 2 Data for Elacestrant in Metastatic Breast Cancer
Menarini and Stemline Therapeutics present pivotal Phase 2 results of Elacestrant (ORSERDU®) in ER+/HER2- metastatic breast cancer at the 2025 San Antonio Breast Cancer Symposium.
third-news.com
December 9, 2025 at 5:40 PM
Menarini and Stemline Reveal Phase 2 Data for Elacestrant in Metastatic Breast Cancer#USA#New_York#Cancer_Research#Menarini#Elacestrant
Menarini Group Unveils Promising Elacestrant Data for Breast Cancer Treatment#USA#Cancer_Research#San_Antonio#Menarini#Elacestrant
Menarini Group Unveils Promising Elacestrant Data for Breast Cancer Treatment
The Menarini Group announces groundbreaking findings on Elacestrant for ER+, HER2- metastatic breast cancer at SABCS 2025, highlighting its effectiveness.
third-news.com
December 8, 2025 at 7:54 PM
Menarini Group Unveils Promising Elacestrant Data for Breast Cancer Treatment#USA#Cancer_Research#San_Antonio#Menarini#Elacestrant
Karyopharm Therapeutics to Join Baird's Biotech Discovery Series Event#Cancer_Research#Karyopharm#XPOVIO
Karyopharm Therapeutics to Join Baird's Biotech Discovery Series Event
Karyopharm Therapeutics is set to participate in the Baird Biotech Discovery Series, featuring insights from expert Dr. Claire Harrison.
third-news.com
December 8, 2025 at 12:14 PM
Karyopharm Therapeutics to Join Baird's Biotech Discovery Series Event#Cancer_Research#Karyopharm#XPOVIO
Brazilian Green Propolis Shows Potential in Reducing Cancer Stem Cell Growth#Japan#Cancer_Research#Okayama#Yamada_Bee_Farm#Green_Propolis
Brazilian Green Propolis Shows Potential in Reducing Cancer Stem Cell Growth
Recent research indicates Brazilian green propolis may help decrease cancer stem cells, potentially inhibiting tumor growth. This was presented at the 84th Annual Meeting of the Japanese Cancer Association.
third-news.com
December 4, 2025 at 1:39 AM
Brazilian Green Propolis Shows Potential in Reducing Cancer Stem Cell Growth#Japan#Cancer_Research#Okayama#Yamada_Bee_Farm#Green_Propolis
Nuvalent Set to Showcase Breakthrough Oncology Research at Upcoming Healthcare Conference#United_States#Cambridge#Cancer_Research#Nuvalent#targeted_therapies
Nuvalent Set to Showcase Breakthrough Oncology Research at Upcoming Healthcare Conference
Nuvalent, Inc., a leader in targeted cancer therapies, will participate in the Piper Sandler Annual Healthcare Conference, highlighting advancements in cutting-edge oncology research.
third-news.com
November 26, 2025 at 11:39 AM
Nuvalent Set to Showcase Breakthrough Oncology Research at Upcoming Healthcare Conference#United_States#Cambridge#Cancer_Research#Nuvalent#targeted_therapies
Revealing the Mysteries of Shapeshifting Cancers: A Breakthrough Study#United_States#Cancer_Research#Cold_Spring_Harbor#Cold_Spring_Harbor,_NY#POUF23
Revealing the Mysteries of Shapeshifting Cancers: A Breakthrough Study
A recent study sheds light on the elusive nature of shapeshifting cancers, uncovering potential targets for therapies that could revolutionize treatment.
third-news.com
November 24, 2025 at 12:44 PM
Revealing the Mysteries of Shapeshifting Cancers: A Breakthrough Study#United_States#Cancer_Research#Cold_Spring_Harbor#Cold_Spring_Harbor,_NY#POUF23